Palo Alto, CA—Aug 6, 2018— SyncThink, a world leader in neurotechnology with foundational IP in eye tracking analytics has partnered with Stanford Children’s Health, a healthcare network exclusively dedicated to pediatric and obstetric care, to initiate a new study utilizing novel technologies in the evaluation of athlete brain health. The multi-year study has already begun enrolling high school aged participants and will look to grow the project to include as many as ten local high schools during the course of the study.
"As part of the Stanford pediatric initiatives supported by the Taube’s generous grant, we have been fortunate to partner with SyncThink to incorporate their novel technology into our studies as we seek to better understand the neurological impairments in high school athletes in our local community," said Stanford Neurosurgeon and Principal Investigator, Gerald Grant MD, FACS. "We see eye tracking assessment as a key metric alongside other advanced technologies, which is also being implemented at all Pac-12 schools.”
Stanford Children’s Health joins a large network of SyncThink platform users. The technology is already in use in more than 30 research and clinical care settings across North America including Massachusetts General Hospital and Walter Reed Army Institute of Research. In addition, the Pac-12 conference, University of Texas, University of Georgia, and the Golden State Warriors have also acquired the technology to improve athlete monitoring and care.
“We are thrilled to partner with an esteemed researcher such as Dr. Grant at a leading pediatric institution. Stanford clearly recognizes the importance of bringing objective measurement to brain health research to give high school athletes the best care possible,” said SyncThink CEO, Laura Yecies.
Stanford Children’s Health is one of the top-ranked pediatric healthcare systems in the country, blending innovation, science, and research with their academic partner Stanford Hospital. In 2018, Stanford Children’s Health was ranked as the top ranked children’s hospital in Northern California.
SyncThink develops revolutionary eye-tracking technology analytics, now in VR headsets, that give medical professionals objective metrics for visual attention and dynamic orientation. Based on 15 years of research and 12 granted patents, SyncThink’s first product, EYE-SYNC, is a 60-second, objective sideline assessment that uses eye tracking to evaluate for ocular motor impairments and ocular vestibular dysfunction – the two most common and serious components of concussion. FDA-cleared for detecting eye-tracking impairment, EYE-SYNC is used by leading university athletic departments and medical clinics, from Stanford University to Massachusetts General Hospital, EYE-SYNC is transforming brain health assessment, recovery, and monitoring.www.syncthink.com